http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004143046-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f6e33603375c486b0ab3505830af9e8 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 |
| filingDate | 2002-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_995aaabb55bb5861c659df3d14dc57d0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb79a821a67cc99719e47d54d5647ca7 |
| publicationDate | 2004-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2004143046-A |
| titleOfInvention | Pharmaceutical containing lipid A1 carboxylic acid analog |
| abstract | An object of the present invention is to provide a compound having an excellent macrophage activity inhibitory activity and useful as an anti-inflammatory agent, an anti-autoimmune disease agent, an immunosuppressant or an anti-sepsis agent. The general formula (I) Embedded image [In the formula, one of R 1 and R 3 is a C9-15 alkyl group, the other is a hydrogen atom or a C1-6 alkyl group, and the other one of R 2 and R 4 is a C10-16 alkenyloxy-substituted C9-alkyl group. 15 alkyl group, the other is, C10-16 alkyl group, R 5 represents a hydroxyl group, C1-6 alkoxy group, a halogen atom. ] Or a pharmacologically acceptable ester thereof or a pharmacologically acceptable salt thereof as an active ingredient. [Selection diagram] None. |
| priorityDate | 2002-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 258.